AJMC® in the Press, October 4, 2024

A newsletter from NYU Langone Health referenced a video interview published on AJMC.com, the website of The American Journal of Managed Care^® (AJMC^®). The interview, “Amivantamab Presents an Exciting Treatment Opportunity in NSCLC,” featured an interview with Joshua K. Sabari, MD, to speak about the 2 FDA approvals for amivantamab to treat non–small cell lung cancer.

An article from Becker’s GI & Endoscopy referenced an article published on AJMC.com. The article, “Updated Colonoscopy Guidelines Have Implications on Doctors, Patients Alike,” featured interviews with the coauthor of the American College of Gastroenterology and American Society for Gastrointestinal Endoscopy colonoscopy guidelines as well as a doctor from Vanderbilt University Medical Center to discuss the implications of the new guidelines and what to expect once they are implemented.

An article from Pharmacy Times referenced an article published AJMC’s sister site, The Center for Biosimilars^®. The article, “FDA Approves First Stelara Biosimilar,” reported on the FDA approval of ustekinumab-auub to treat moderate to severe plaque psoriasis, active psoriatic arthritis, Crohn disease, and moderately to severely active ulcerative colitis.